Clinical Trial Update: The Potential of Candesartan to Retard the Progression of Aortic Stenosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating candesartan to slow progression of aortic valve stenosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Candesartan (candesartan)

Snippet

Sponsor: University of Helsinki | Conditions: Aortic Valve Stenosis | Phase 3 | Status: UNKNOWN